Therapeutic Implications of Recent Growth Factor Research
| Autor: | M. N. Pollak |
|---|---|
| Rok vydání: | 1991 |
| Předmět: |
Oncology
medicine.medical_specialty biology business.industry medicine.medical_treatment Growth factor medicine.disease Metastatic breast cancer Pathophysiology Breast cancer Epidermal growth factor Internal medicine medicine biology.protein Adjuvant therapy Epidermal growth factor receptor business Adjuvant |
| Zdroj: | High-Risk Breast Cancer ISBN: 9783642747304 |
| DOI: | 10.1007/978-3-642-74728-1_26 |
| Popis: | Despite recent advances, current therapies for metastatic breast cancer rarely achieve response rates greater than 60%, and complete responses are rare. Adjuvant treatment of certain stage I and II breast cancer patients can improve survival compared with untreated patients, but relapse following adjuvant therapy remains a common problem, as does our inability to determine which individual patients are most likely to benefit from adjuvant treatment. Current laboratory research concerning the involvement of peptide growth factors in the pathophysiology of breast cancer is providing clues that suggest new approaches to these clinical challenges. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|